Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Osterhaus, Patrick
49  Ergebnisse:
Personensuche X
?
1

Factors Contributing to Delay in Specialist Care After Colo..:

Chow, Zeta ; Osterhaus, Patrick ; Huang, Bin...
Journal of Surgical Research.  259 (2021)  - p. 420-430 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Factors Contributing to Delay in Specialist Care after Colo..:

Chow, Zeta ; Osterhaus, Patrick ; Huang, Bin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897242/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
3

Pharmacokinetics of Oral and Intravenous Oseltamivir Treatm..:

Karsch, Katharina ; Chen, Xi ; Miera, Oliver...
European Journal of Drug Metabolism and Pharmacokinetics.  42 (2016)  1 - p. 155-164 , 2016
Link: https://doi.org/10.1007/..
 
?
4

Correction: Altered Protein Networks and Cellular Pathways ..:

Fraisier, Christophe ; Camoin, Luc ; Lim, Stephanie M....
PLoS ONE.  8 (2013)  12 - p. , 2013
Link: https://doi.org/10.1371/..
 
?
5

Altered Protein Networks and Cellular Pathways in Severe We..:

Fraisier, Christophe ; Camoin, Luc ; Lim, Stéphanie...
PLoS ONE.  8 (2013)  7 - p. e68318 , 2013
Link: https://doi.org/10.1371/..
 
?
6

Make science evolve into a One Health approach to improve h..:

Osterhaus, Albert D. M. E. ; Vanlangendonck, Chris ; Barbeschi, Maurizio...
One Health Outlook.  2 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
7

DC immunotherapy in HIV-1 infection induces a major blood t..:

de Goede, Anna L. ; Andeweg, Arno C. ; van den Ham, Henk-Jan...
Vaccine.  33 (2015)  25 - p. 2922-2929 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-..:

Allard, Sabine D. ; De Keersmaecker, Brenda ; de Goede, Anna L....
Clinical Immunology.  150 (2014)  1 - p. 88-89 , 2014
Link: https://doi.org/10.1016/..
 
?
9

H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R..:

van der Vries, Erhard ; Collins, Patrick J. ; Vachieri, Sebastien G....
PLoS Pathogens.  8 (2012)  9 - p. e1002914 , 2012
Link: https://doi.org/10.1371/..
 
?
10

A phase I/IIa immunotherapy trial of HIV-1-infected patient..:

Allard, Sabine D. ; De Keersmaecker, Brenda ; de Goede, Anna L....
Clinical Immunology.  142 (2012)  3 - p. 252-268 , 2012
Link: https://doi.org/10.1016/..
 
?
11

Characterization of recombinant influenza A virus as a vect..:

de Goede, Anna L. ; Boers, Patrick H.M. ; Dekker, Lennard J.M....
Vaccine.  27 (2009)  42 - p. 5735-5739 , 2009
Link: https://doi.org/10.1016/..
 
?
12

Functional T-cell responses generated by dendritic cells ex..:

Allard, Sabine D. ; Pletinckx, Katrien ; Breckpot, Karine...
Vaccine.  26 (2008)  29-30 - p. 3735-3741 , 2008
Link: https://doi.org/10.1016/..
 
?
13

In vitro replication capacity of HIV-2 variants from long-t..:

Blaak, Hetty ; van der Ende, Marchina E. ; Boers, Patrick H.M...
Virology.  353 (2006)  1 - p. 144-154 , 2006
Link: https://doi.org/10.1016/..
 
?
14

Contributors:

, In: Mucosal Immunology,
Abd-Alla, Mohammed D. ; Abraham, Soman N. ; Adams, David... - p. xv-xxv , 2005
Link: https://doi.org/10.1016/..
 
?
15

Construction and characterisation of infectious recombinant..:

Guillon, Christophe ; van Baalen, Carel A. ; Boers, Patrick H.M....
Journal of Virological Methods.  99 (2002)  1-2 - p. 115-121 , 2002
Link: https://doi.org/10.1016/..
 
1-15